Barros, Renata C. H., and Luiz G. S. Branco. Central dopamine modulates anapyrexia but not hyperventilation induced by hypoxia. J Appl Physiol 92: 975-981, 2002; 10.1152/japplphysiol.00852.2001.-Hypoxia causes hyperventilation and decreases body temperature (Tb) and metabolism [O2 consumption (V O2)]. Because dopamine (DA) is released centrally in response to peripheral chemoreceptor stimulation, we tested the hypothesis that central DA mediates the ventilatory, thermal, and metabolic responses to hypoxia. Thus we predicted that injection of haloperidol (a DA D2-receptor antagonist) into the third ventricle would augment hyperventilation and attenuate the drop in Tb and V O2 in conscious rats. We measured ventilation, Tb, and V O2 before and after intracerebroventricular injection of haloperidol or vehicle (5% DMSO in saline), followed by a 30-min period of hypoxia exposure. Haloperidol did not change Tb or V O2 during normoxia; however, breathing frequency was decreased. During hypoxia, haloperidol significantly attenuated the falls in Tb and V O2, although hyperventilation persisted. The present study shows that central DA participates in the thermal and metabolic responses to hypoxia without affecting hyperventilation, showing that DA is not a common mediator of this interaction.
RESPIRATORY, THERMAL, and metabolic adjustments have been reported to attenuate changes in O 2 supply during hypoxia (3) . At first sight, these responses appear to occur in opposite directions, i.e., increases in ventilatory drive and decreases in metabolism and body temperature (T b ) (13) . However, this impression may reflect the complexity of the still unknown mechanisms and neuromodulators involved in these responses.
Goiny et al. (16) reported dopamine (DA) accumulation in the nucleus tractus solitarius (NTS) in response to peripheral chemoreceptor stimulation in rabbits and attributed this accumulation to the roll-off phenomenon of the biphasic ventilatory response to hypoxia. This response consists of an early rise in ventilation (V ) followed by a subsequent decline or roll-off from peak values (34) . The roll-off is thought to be of central origin because chemoreceptor output does not change during its occurrence (32) . In addition, Long and Anthonisen (26) reported that systemic administration of haloperidol, a DA D 2 -receptor antagonist that crosses the blood-brain barrier, decreases the roll-off in awake cats, supporting the notion that DA in the brain stem may influence sustained hypoxic hyperventilation.
No reports are available about the role of DA in the mediation of T b reduction during hypoxia. However, several studies show that DA may be involved in thermoregulation, because agonists cause hypothermia (27, 30) . If the roll-off of the hypoxic ventilatory response coincided with the drops in T b and metabolism, the respiratory and metabolic interaction during hypoxia would no longer be conflicting and DA would be a potential candidate to play a role in this interaction. However, the biphasic ventilatory response to hypoxia is not a universal response. It is consistently found in neonates and anesthetized adult animals (34) , but only conscious adult humans (10) , cats (35) , and squirrels (3) have been reported to exhibit this response. In addition, studies using systemic haloperidol could not exclude its effects on the periphery, specifically on the carotid bodies, where DA is released during hypoxia (17) .
With the objective to elucidate the interaction between V , T b , and metabolism during hypoxia in awake rats, we tested the hypothesis that central DA mediates simultaneously the ventilatory, thermal, and metabolic responses to hypoxia so that hyperventilation will be augmented and the reductions in T b and metabolism will be attenuated by haloperidol administration into the third ventricle.
METHODS

Animals
Experiments were performed on adult male Wistar rats (Rattus norvegicus, Rodentia: Muridae) weighing 274.0 Ϯ 12.0 g, housed at controlled temperature (25 Ϯ 1°C), and exposed to a daily 12:12-h light-dark cycle. The animals were allowed free access to water and food. The rats used in this study were divided into five major groups: 1) central haloperidol injection (n ϭ 7), 2) central vehicle injection (n ϭ 5), 3) intravenous (IV) haloperidol injection (n ϭ 5), 4) IV vehicle injection (n ϭ 5), and 5) a control group (n ϭ 8).
Surgery
Animals were submitted to general anesthesia with intraperitoneal administration of 2,2,2-tribromoethanol (250 mg/ kg; Aldrich, Milwaukee, WI). Rats of the central haloperidol and vehicle injection groups were fixed in a stereotaxic frame and implanted with a stainless steel guide cannula (0.7 mm OD) into the third ventricle (coordinates: anterior Ϫ0.4 mm, lateral 0 mm, dorsal 7.8-8.5 mm) for intracerebroventricular (ICV) administration. The displacement of the meniscus in a water manometer ensured correct positioning of the cannula in the third ventricle. The cannula was attached to the bone with stainless steel screws and acrylic cement. A tight-fitting stylet was kept inside the guide cannula to prevent occlusion. In the animals of the IV haloperidol and vehicle injection groups, a catheter was inserted into the femoral vein, tunneled subcutaneously, and exteriorized through the back of the neck. Animals of all groups were submitted to paramedian laparotomy for the insertion of a biotelemetry capsule (model VM-FH, Mini-Mitter, Sunriver, OR) into the peritoneal cavity. The wound was then closed, and the implanted capsule was used for T b measurement. At the end of the surgical procedures, animals received 100,000 units of benzyl-penicillin. Only the latter surgery was performed in the control group. Experiments were initiated 1 wk after surgeries in the ICV haloperidol or vehicle injection groups and 2 days after surgeries in the IV haloperidol or vehicle injection and control groups.
Determination of V
Measurements of V were performed by the body plethysmograph method (4) .
During V measurements, the flow was interrupted, the chamber was sealed for short periods of time (ϳ2 min), and the oscillations in air temperature caused by breathing could be measured as pressure oscillations. This procedure was performed once during each time of V measurement. Signals from an air differential transducer (Validyne) were collected by a differential pressure signal conditioner (Gold), passed through an analog-to-digital converter, digitized in a microcomputer equipped with data-acquisition software (Acquire 6600 data acquisition system, Gold Instrument Systems, Valley View, OH), and then analyzed with data-analysis software (Windaq). Calibration for volume was obtained during each experiment by injecting the animal chamber with a known amount of air (1 ml) using a graduated syringe. Two respiratory variables were measured, respiratory frequency (f) and tidal volume (VT), the latter being calculated by the
, where PT is the pressure deflection associated with each VT, PK is the pressure deflection associated with injection of the calibration volume (VK), PB is the barometric pressure, P C is the vapor pressure of water vapor in the animal chamber, T C is the air temperature in the animal chamber, and PR is the vapor pressure of water at Tb. V was calculated by multiplying f by VT. V and VT are presented at the ambient barometric pressure, at T b, and saturated with water vapor at this temperature (BTPS).
Determination of T b
Tb was measured by biotelemetry. The animal chamber was placed on the RLA 3000 telemetry receiver (Mini-Mitter). The output of the receiver displayed the pulse frequency of the transmitter capsule and the corresponding T b in a microcomputer containing appropriate software (Vital View).
Determination of Oxygen Consumption
Oxygen consumption (V O2) was measured with a closedflow system using an oxygen analyzer (type OA.272, Saylor Servomex). Each time V O2 was measured, the flow was interrupted, the chamber was sealed, and six samples of chamber air (30 ml) were taken at 2-min intervals and passed through the O 2 analyzer. Therefore, the chamber remained sealed for 10 min, the time needed to collect sufficient data to obtain accurate slopes. Assuming a respiratory exchange ratio (CO 2 production/V O2) of 0.8, which is a general rule for air breathers (9), and considering the measured V O2, at the end of the 10-min period the CO2 level inside the chamber will be ϳ0.6%. Our laboratory has previously shown that hypercapnia, even at high levels of 5 and 10% CO 2, does not alter the V O2 of rats (2) . A curve of %O2 evolution was constructed, and its slope gave the value of V O2. This metabolic variable is reported at STPD.
Experimental Protocol
Measurements of V and Tb were made in the same set of experiments, whereas V O2 was obtained in a separate experiment. Animals were exposed first to humidified room air and then to a humidified hypoxic poikilocapnic gas mixture containing 7% O 2 (AGA). Each animal was exposed to hypoxia only once and received only one injection of haloperidol or vehicle. Experiments were carried out randomly between 8:00 AM and 1:00 PM.
Determination of the effect of hypoxia on V , T b, and V O2. One week after biotelemetry capsule implantation, control group animals were individually placed in a Plexiglas chamber (5 liters) and allowed to move about freely while the chamber was flushed with humidified air. After the animals remained calm (ϳ30 min), control V and T b were measured, and the test gas mixture (7% inspired O2) was flushed through the chamber for 30 min. V and Tb were measured after 30 min of hypoxia. The same procedure was repeated to measure V O2 before and after hypoxia exposure.
Determination of the effect of haloperidol on V , Tb, and V O2 before and after hypoxia. Each animal in the vehicle and haloperidol groups was placed in the same chamber, which was flushed with room air. After the animals remained calm, control V was measured, and T b started to be continuously measured at 5-min intervals. Subsequently, experimental rats were treated with a haloperidol (Sigma Chemical) dose of 0.5 g/animal in 2 l injected into the third ventricle or the same dose in 0.25 ml injected intravenously, whereas the vehicle groups received the same volumes of 5% DMSO in saline (150 mM NaCl). 5% DMSO in saline was the vehicle in which haloperidol was dissolved. V was measured 5, 15, 20, 30, 40, and 50 min after haloperidol or vehicle administration. Subsequently, the test gas mixture of 7% inspired O 2 was flushed through the chamber for 30 min. V was measured after 5, 15, 20, and 30 min during hypoxia. Finally, rats were returned to a 30-min period of normoxic exposure, when V was measured again after 5, 15, 20, and 30 min.
The same experimental procedure was repeated to measure basal, hypoxic, and posthypoxic V O2. The haloperidol dose and period of time after its injection were chosen on the basis of previous studies (21, 26) , with the objective to use a low but effective dose, to avoid sedative effects and to obtain a steady-state response of all variables measured, considering the long half-life of the drug. Because haloperidol induces catalepsy (a failure to correct an externally imposed posture), at the end of each experiment, animals were submitted to a catalepsy test (12) to ascertain the effectiveness of the drug. Thus animals were grasped gently, and their front paws were placed over a horizontal 10-cm-high bar. The time until both forepaws touched the floor or until the maximum time allowed in the experiment was reached (5 min) was measured.
Data Analysis
The air convection requirement (ACR or V /V O2) was calculated from the V and metabolic mean values (V /V O2) to determine whether putative changes in metabolism would reflect in significant changes in V . To remove the effects of T b alterations, the values for V were corrected for the fall in Tb using a temperature coefficient called Q10, which is a fraction of increase or decrease in a rate when temperature is increased or decreased by 10°C; Q 10 ϭ ͑V 2 /V 1 ͒ 10/T2 Ϫ T1 , where V1 is the measured V , V2 is the fictive V that was being calculated, T1 is the measured Tb, and T2 is the fixed Tb (control value). Q10 values of 2 and 3 were assumed, because they represent the normal range for most chemical and physiological processes (e.g., Ref.
3).
Values are reported as means Ϯ SE (unless otherwise stated). The effects of drug treatment and time course of hypoxia on V , VT, f, Tb, and V O2 were evaluated by two-way ANOVA. When statistical differences were found, one way-ANOVA and the Tukey-Kramer multiple-comparisons test were applied as a post hoc test. Point-by-point comparisons between mean values were performed by Student's t-test. Values of P Ͻ 0.05 were considered to be significant.
RESULTS
During the experiments, the mean chamber temperature was 24.4 Ϯ 0.8°C (mean Ϯ SD), and room temperature was 23.5 Ϯ 0.7°C (mean Ϯ SD).
Effect of Hypoxia on V , T b , and V O 2
Control animals showed significant increases in VT, f, and V and decreases in T b and V O 2 after 30 min of hypoxia exposure compared with basal measurements in normoxia (Table 1) .
Effect of Haloperidol on V , T b , and V O 2 Before and After Hypoxia
Before any treatment, basal VT, f, V , T b , and V O 2 of rats in the vehicle and haloperidol groups (Figs. 1-3 and Table 2 ) were similar to those of control rats (Table  1) . Under normoxic conditions, ICV or IV vehicle injection did not elicit any significant changes in VT, f, V , T b , or V O 2 (Figs. 1-3 and Table 2 ), whereas central haloperidol caused a drop in f, which was significant 15 min after its injection (Fig. 1B) . During hypoxia, no significant difference in VT, V , or even f was detected between the vehicle and haloperidol groups, because hypoxia caused a similar sustained increase in VT, f, and V in all groups ( Fig. 1 and Table 2 ). However, the decreases in T b and V O 2 induced by hypoxia observed in the control (Table 1) and vehicle groups were attenuated in the central haloperidol group (Figs. 2 and 3) but not in the IV haloperidol injection group. After hypoxia exposure, the basal VT, V , T b , and V O 2 values of all ϩ Significant differences between haloperidol and vehicle treatments (P Ͻ 0.05; two-way ANOVA).
vehicle and haloperidol groups were recovered within 30 min of normoxia, whereas f returned to the low value induced by ICV haloperidol injection.
Changes in respiratory variables occurred concurrently with the fall in T b and metabolism. Thus calculations of the ratio of V to metabolism (ACR) and V correction for T b fall provide information about the interaction of the variables. Figure 4 shows that ACR increased more in animals of the vehicle group than in rats treated with haloperidol, because of the attenuation in the V O 2 drop in the latter. Figure 5 shows that the increase in corrected V (Q 10 ϭ 2 or 3) due to hypoxia was modestly higher than raw data and similar in both groups, confirming that central haloperidol has no effects on V .
Although no difference in animal behavior was observed between the vehicle and haloperidol groups, only rats treated with haloperidol exhibited catalepsy at the end of each experiment (Table 3) .
DISCUSSION
This study provides the first evidence that central DA is a neuromodulator involved in thermoregulation during hypoxia, because the drop in T b and metabolism elicited by hypoxia was attenuated when central DA transmission was blocked with haloperidol. However, haloperidol did not affect the sustained hypoxic hyperventilation, indicating that DA has no effects on breathing regulation during hypoxia, at least in the unanesthetized rat that did not exhibit the biphasic ventilatory response to hypoxia. Moreover, the data also indicate that more than one neuromodulator is involved in the ventilatory and metabolic responses to hypoxia.
The basal V (1, 2), T b (1, 2), and V O 2 (2) values of Wistar rats measured in the present study agree with previous reports. As also shown in earlier studies with rats, hypoxia caused hyperventilation (14) and drops in T b (5, 36) and V O 2 (13) . In addition, hypoxia did not elicit a biphasic ventilatory response in the awake rats Values are expressed as means Ϯ SE; n ϭ 7 and 5 for haloperidol and vehicle groups, respectively. * Significant effects of hypoxia compared with control values (P Ͻ 0.05; two-way ANOVA).
ϩ Significant differences between haloperidol and vehicle treatments (P Ͻ 0.05; two-way ANOVA). Values are means Ϯ SE; n ϭ 5 animals in each group. * Significant effect of hypoxia compared with control values (P Ͻ 0.05; Student's t-test). used in the present study, corroborating the data obtained by Gautier and Murariu (14) . Actually, the biphasic ventilatory response to hypoxia seems to be consciousness state, age, and species dependent (1, 14, 10, 34, 35) . Demonstrating the effectiveness of the haloperidol dose used in our study, all rats treated with the drug showed catalepsy at the end of experiments, because 10 s of immobility in the imposed posture are already considered significant for Wistar rats (12) . However, the dose that we used was low enough to avoid sedative effects that could interfere with the behavior of the animals and alter V , T b , or metabolism.
Effects of Central Haloperidol on V Before and After Hypoxia
DA is released from chemoafferent fibers stimulated by hypoxia inside the NTS, and its accumulation was suggested to induce, at least in part, the decline of hyperventilation of rabbits and cats (16, 26) . However, the rats of the present study did not exhibit a biphasic ventilatory response to hypoxia or any other inhibitory effect of DA, because central haloperidol injection did not affect sustained hypoxic hyperventilation.
There are many contradictory results in the available literature about the role of DA in breathing regulation. Actually, some of several studies that investigated the central effects of DA using systemic administration of haloperidol reported that DA stimulates ventilatory responses to hypoxia (23, 31) , whereas other studies found that DA may attenuate hypoxic hyperventilation (26, 28, 32) . Our study, which is the only one with the central injection of haloperidol addressing this issue, detected none of these facts, suggesting that any excitatory or inhibitory effect of DA may originate in the periphery. The main site may be the carotid bodies, where DA is released from glomus cells during hypoxia exposure (17) . Although most studies reported that DA in the carotid body has an inhibitory effect, because tonic D 2 -receptor blockade with domperidone increases carotid sinus nerve activity (23, 33) , excitatory actions may exist. In fact, Hedner et al. (21) reported that DA injected intravenously stimulates f in anesthetized rats. Some of these opposing and complex results may be explained by the fact that DA can activate both pre-and postsynaptic D 2 receptors in the carotid bodies (18) , and its inhibitory effect seems to be a feedback control of DA release through presynaptic D 2 receptors (17). In addition, DA and its agonists are reported to inhibit carotid sinus nerve discharges at low doses and to increase them at high doses, whereas antagonists of DA seem to increase carotid sinus nerve discharges at low doses and to inhibit them at high doses (18) . The affinity of DA presynaptic receptors is much higher than that of postsynaptic receptors (18) , and, therefore, when haloperidol is injected peripherally at high doses, it may have inhibitory effects on carotid bodies. Regarding another peripheral effect of haloperidol that may influence the ventilatory response to hypoxia, Tatsumi et al. (33) reported that systemic blood pressure is decreased after IV haloperidol administration (0.1 mg/kg), probably through the effects of the drug on ␣-adrenergic receptors. Several previous studies using systemic injection of haloperidol to determine the central effects of DA have used the same (26) or even higher doses (23, 24, 31) .
Thus central DA seems to have a tonic excitatory role in resting f but no significant effect on breathing during hypoxia. Hedner et al. (21) showed that, when haloperidol or domperidone was injected into the lateral ventricles of normoxic rats, at continuously increasing doses, a depression of f was recorded at doses of 30 and 300 g, whereas VT increased, and thus there was no significant alteration or even a drop in V . These results are similar to those of the present study. In addition, animals in which central DA neurons were destroyed at birth with intracisternally administered 6-hydroxydopamine show a decreased basal V (e.g., Ref. 21) . Actually, if data using central injection of DA agonists and antagonists indicate that DA has excitatory effects on V in the central nervous system (CNS) during normoxia, it would be unusual if DA accumula- tion during hypoxia caused depression in V . Our data showing that central haloperidol has no effects on breathing regulation during hypoxia suggest that the probable DA released in the NTS does not actually act on breathing control of awake rats but may be involved in other adjustments that may serve to attenuate changes in the O 2 supply, such as cardiovascular and thermal regulation (3) . On the other hand, our data do not disagree with the idea that the DA is a crucial mediator involved in breathing regulation during hypoxia, especially concerning its peripheral effects. A recent study on D 2 -receptor-deficient mice has provided strong evidence that DA participates in the hypoxic ventilatory response, because V of these animals was higher than that of wild mice during acute hypoxia exposure (25) .
Effects of Haloperidol on T b and V O 2 Before and After Hypoxia
Hypoxia reduces T b and metabolism of newborns and adults of many species (15, 22) , including humans (8) . Hypoxia also leads animals to select ambient temperatures that favor T b values below those seen in normoxia, suggesting the occurrence of a drop in the set point for thermoregulation (19, 36) . That is why such T b drop has been called anapyrexia (6) , instead of hypothermia. Moreover, hypoxic anapyrexia is considered to be a beneficial response (36) . According to these previous reports, hypoxic anapyrexia was accompanied by a drop in metabolism in the present study, which may serve to attenuate changes in O 2 supply in vital tissues.
Hasegawa et al. (20) measured an elevation in the level of DA metabolites in the preoptic area and anterior hypothalamus by microdialysis in rats submitted to treadmill exercise showing a sustained increase in T b and suggested that DA is involved in the activation of heat loss mechanisms to prevent hyperthermia during exercise. Our data showing that central haloperidol attenuates the hypoxic anapyrexia are in agreement with the notion of a stimulatory effect of DA on heat loss mechanisms.
Because haloperidol blunted but did not abolish the drop in T b induced by hypoxia, a cooperative action of other modulators may be necessary to trigger a fullblown hypoxic anapyrexia. In fact, recent data indicate that the role of the CNS in thermoregulation during hypoxia is subjected to numerous modifiers, such as adenosine (14) , lactate (29) , and opioids (14) . Among them, nitric oxide seems to be a proximal mediator of several anapyretic stimuli (5, 7), which may suggest a common final pathway.
The attenuation of the T b drop induced by hypoxia after haloperidol treatment was accompanied by a reduction in V O 2 drop. Because the drop in T b during hypoxia influences but is not the cause of the V O 2 drop (3), central DA may also affect regulation of metabolism. Actually, our laboratory reported in a previous study that squirrels are able to maintain or elevate their metabolic rates when ambient temperature is reduced during hypoxia (7% O 2 ), suggesting that O 2 is not limiting and that they can regulate their metabolism (3). One possible site of central DA action to regulate metabolism during hypoxia could also involve T b regulation; i.e., DA may also inhibit mechanisms of heat production. Thus further studies are needed to assess the thermal and metabolic roles of DA in the hypothalamus during hypoxic stress.
Conclusions
The present study shows that central DA affects thermal and metabolic responses to hypoxia without changing hyperventilation. Thus DA is not a common mediator of this interaction. Even the attenuation of hypoxia-induced drops in T b and metabolism with haloperidol had no effect on breathing, as illustrated by Figs. 4 and 5. Both ACR and corrected V were very similar between animals of the vehicle and control groups. Although some modulators released by hypoxia in the CNS may have simultaneous effects on respiratory and thermoregulatory systems, such as adenosine (1) and nitric oxide (11) , which attenuate hyperventilation and play a role in T b and V O 2 drops during hypoxia, the present data indicate that other mediators, like DA, may regulate each system independently. DA may act by stimulating central mechanisms of heat loss and inhibiting those of heat production, leading to a regulated drop in T b and metabolism, as a protective response to decreased O 2 demand.
The contribution to the understanding of the interaction among V , T b , and hypoxia is essential, not only to the understanding of the strategies of animals that live in hypoxic conditions but also to provide some insights concerning the protective effects of hypothermia in experimental and clinical settings when the oxygen supply is reduced.
